BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 29412048)

  • 41. Biotransformation of L-ornithine from L-arginine using whole-cell recombinant arginase.
    Zhan Y; Liu J; Mao P; Zhang H; Liu Q; Jiao Q
    World J Microbiol Biotechnol; 2013 Nov; 29(11):2167-72. PubMed ID: 23700128
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered nitric oxide synthase, arginase and ornithine decarboxylase activities, and polyamine synthesis in response to ischemia of the rabbit detrusor.
    Kawano K; Masuda H; Yano M; Kihara K; Sugimoto A; Azuma H
    J Urol; 2006 Jul; 176(1):387-93. PubMed ID: 16753448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells.
    Singh R; Pervin S; Karimi A; Cederbaum S; Chaudhuri G
    Cancer Res; 2000 Jun; 60(12):3305-12. PubMed ID: 10866325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. There is no direct competition between arginase and nitric oxide synthase for the common substrate l-arginine.
    Momma TY; Ottaviani JI
    Nitric Oxide; 2022 Dec; 129():16-24. PubMed ID: 36126859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Melatonin modulates L-arginine metabolism in tumor-associated macrophages by targeting arginase 1 in lymphoma.
    Kumari A; Syeda S; Rawat K; Kumari R; Shrivastava A
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):1163-1179. PubMed ID: 37639022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An arginase-1 SNP that protects against the development of pulmonary hypertension in bronchopulmonary dysplasia enhances NO-mediated apoptosis in lymphocytes.
    Trittmann JK; Jin Y; Chicoine LG; Liu Y; Chen B; Nelin LD
    Physiol Rep; 2016 Nov; 4(22):. PubMed ID: 27895230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Disorders of endothelium-dependent vascular reactions and of the arginase and NO-synthase pathways of L-arginine metabolism in arterial hypertension].
    Sahach VF; Baziliuk OV; Kotsiuruba AV; Buzhanevich OM
    Fiziol Zh (1994); 2000; 46(3):3-13. PubMed ID: 11059380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relationship of plasma arginine and kidney arginase activity to arginine degradation in chickens.
    Chu SW; Nesheim MC
    J Nutr; 1979 Oct; 109(10):1752-8. PubMed ID: 490213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular dysfunction in retinopathy-an emerging role for arginase.
    Caldwell RB; Zhang W; Romero MJ; Caldwell RW
    Brain Res Bull; 2010 Feb; 81(2-3):303-9. PubMed ID: 19737603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged mice.
    Shin WS; Berkowitz DE; Ryoo SW
    Exp Mol Med; 2012 Oct; 44(10):594-602. PubMed ID: 22854495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of a chronic l-arginine supplementation on the arginase pathway in aged rats.
    Moretto J; Guglielmetti AS; Tournier-Nappey M; Martin H; Prigent-Tessier A; Marie C; Demougeot C
    Exp Gerontol; 2017 Apr; 90():52-60. PubMed ID: 28132871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Arginase inhibition alleviates hypertension in the metabolic syndrome.
    El-Bassossy HM; El-Fawal R; Fahmy A; Watson ML
    Br J Pharmacol; 2013 Jun; 169(3):693-703. PubMed ID: 23441715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regional variations and age-related changes in nitric oxide synthase and arginase in the sub-regions of the hippocampus.
    Liu P; Smith PF; Appleton I; Darlington CL; Bilkey DK
    Neuroscience; 2003; 119(3):679-87. PubMed ID: 12809689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Candida albicans Chitin Increases Arginase-1 Activity in Human Macrophages, with an Impact on Macrophage Antimicrobial Functions.
    Wagener J; MacCallum DM; Brown GD; Gow NA
    mBio; 2017 Jan; 8(1):. PubMed ID: 28119468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
    Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
    J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Macrophage arginine metabolism to ornithine/urea or nitric oxide/citrulline: a life or death issue.
    Mills CD
    Crit Rev Immunol; 2001; 21(5):399-425. PubMed ID: 11942557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arginine attenuates methylglyoxal- and high glucose-induced endothelial dysfunction and oxidative stress by an endothelial nitric-oxide synthase-independent mechanism.
    Dhar I; Dhar A; Wu L; Desai K
    J Pharmacol Exp Ther; 2012 Jul; 342(1):196-204. PubMed ID: 22518022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maternal hypercholesterolemia in pregnancy associates with umbilical vein endothelial dysfunction: role of endothelial nitric oxide synthase and arginase II.
    Leiva A; de Medina CD; Salsoso R; Sáez T; San Martín S; Abarzúa F; Farías M; Guzmán-Gutiérrez E; Pardo F; Sobrevia L
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2444-53. PubMed ID: 23950140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urea cycle of Fasciola gigantica: purification and characterization of arginase.
    Mohamed SA; Fahmy AS; Mohamed TM; Hamdy SM
    Comp Biochem Physiol B Biochem Mol Biol; 2005 Nov; 142(3):308-16. PubMed ID: 16125991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platelet aggregation in arterial hypertension: is there a nitric oxide-urea connection?
    Moss MB; Siqueira MA; Mann GE; Brunini TM; Mendes-Ribeiro AC
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):167-72. PubMed ID: 19566824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.